Cancer News and Research

Latest Cancer News and Research

KSU researcher completes study that examines dietary fiber in children

Experts have long since determined the recommended daily amounts of certain nutrients, such as calcium and vitamin D, but the numbers for nutrients like fiber have proven more difficult to nail down.

31 Jul 2012

Young women with indoor tanning habits frequently experience sunburn

Controversy remains over the risks involved with indoor tanning, especially in children and young adults. Since sunburn serves as a marker for excessive and skin-cell damaging ultraviolet (UV) exposure -- which can eventually lead to the development of skin cancer -- investigators at The Cancer Institute of New Jersey (CINJ) took a closer look at a college-aged sample of females and their indoor tanning habits.

31 Jul 2012

Photoacoustics limited in its ability to identify multiple types of cancer

One person dies every hour from melanoma skin cancer in the United States, according to the American Cancer Society. A technique, known as photoacoustics, can find some forms of melanoma even if only a few cancerous cells exist, but a recent study by MU researchers found that the technique was limited in its ability to identify other types of cancer.

31 Jul 2012

TAU researcher reveals link between plant and human biology

Increasingly, scientists are uncovering surprising biological connections between humans and other forms of life. Now a Tel Aviv University researcher has revealed that plant and human biology is much closer than has ever been understood - and the study of these similarities could uncover the biological basis of diseases like cancer as well as other "animal" behaviors.

31 Jul 2012

Two new targets could enhance the body's defenses against West Nile and hepatitis C

Two new targets have been discovered for antiviral therapies and vaccines strategies that could enhance the body's defenses against such infectious diseases as West Nile and hepatitis C. The targets are within the infection warning system inside living cells.

31 Jul 2012

EPHA3 mutations may be important drivers of lung cancers

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

31 Jul 2012

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

As liver cancer develops, tumor cells lose the ability to produce and release glucose into the bloodstream, a key function of healthy liver cells for maintaining needed blood-sugar levels.

31 Jul 2012

Viewpoints: Health law no threat to innovation; Failure to expand Medicaid would 'doom' thousands; Don't stigmatize mentally ill

For better or worse, the Democrats incorporated a good deal of mainstream Republican thinking about health care reform from the past decade, including mandated coverage and health insurance exchanges, into the Affordable Care Act. This leaves the GOP, embarrassingly, with little to say about what is wrong with the act.

31 Jul 2012

Cancer therapy provides relief for painful foot condition

Research shows that external beam radiation therapy, similar to that used in treating cancer, provides effective pain relief for patients with plantar fasciitis.

30 Jul 2012

HPV co-testing prospect for HIV-infected women

The risk for cervical precancer and cancer is similar in HIV-infected and HIV-uninfected women with normal cervical cytology and no evidence of oncogenic human papillomavirus infection, research shows.

30 Jul 2012

Study sheds light on complexities of cancer genetics

By studying fruit flies, scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have successfully devised a fast and cost-saving way to uncover genetic changes that have a higher potential to cause cancer.

30 Jul 2012

Biovest receives Rapporteur and Co-Rapporteur designation for BiovaxID personalized cancer vaccine

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has notified Biovest regarding the official designation of the Rapporteur and Co-Rapporteur for BiovaxID, a personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma.

30 Jul 2012

FDA grants Senesco's SNS01-T orphan-drug designation to treat lymphomas

Senesco Technologies, Inc. reported today that it was informed on July 26th that the U.S. Food and Drug Administration has granted orphan-drug designation for the company's lead drug candidate SNS01-T for treatment of both mantle cell lymphoma and diffuse large B-cell lymphoma.

30 Jul 2012

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

The antioxidants that we mainly looked at were selenium, vitamin C and vitamin E. They are chemicals which inactivate pro-oxidants or free radicals. Smoking and normal metabolism can lead to the production of free radicals.

30 Jul 2012

Promising implications for improving cellular immunotherapy for treatment of cancer

New research from the Trudeau Institute laboratory of Dr. Edward L. Pearce (Washington University) has promising implications for improving a treatment for cancer known as cellular immunotherapy. The findings were just published in the The Journal of Immunology.

30 Jul 2012

Positive results from Vermillion OVA500 multi-center study for ovarian cancer

Vermillion, Inc., a leading molecular diagnostics company, today announced positive results from a new prospective, multi-center clinical study of its ovarian cancer diagnostic OVA1.

30 Jul 2012

Advaxis reports continued positive patient survival pattern in ADXS-HPV Phase 2 cervical cancer trial

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, presented updated preliminary data from an ongoing randomized Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.

30 Jul 2012

FDA accepts Exelixis’ cabozantinib NDA for filing

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).

30 Jul 2012

MCW, Transgenomic partner to offer next-generation genetic testing services

Transgenomic, Inc. and the Medical College of Wisconsin today announced a collaboration agreement under which Transgenomic will offer next-generation genetic testing services performed at the MCW Clinical Sequencing Program. These services will initially include Transgenomic's NuclearMitome Test for mitochondrial disorders.

30 Jul 2012

PSA testing and early detection may prevent 17,000 men each year from prostate cancer

A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.

30 Jul 2012

Cancer News and Research

Latest Cancer News and Research

KSU researcher completes study that examines dietary fiber in children

Young women with indoor tanning habits frequently experience sunburn

Photoacoustics limited in its ability to identify multiple types of cancer

TAU researcher reveals link between plant and human biology

Two new targets could enhance the body's defenses against West Nile and hepatitis C

EPHA3 mutations may be important drivers of lung cancers

Gluconeogenesis severely compromised in HCC by IL6-Stat3-mediated activation of miR-23a

Viewpoints: Health law no threat to innovation; Failure to expand Medicaid would 'doom' thousands; Don't stigmatize mentally ill

Cancer therapy provides relief for painful foot condition

HPV co-testing prospect for HIV-infected women

Study sheds light on complexities of cancer genetics

Biovest receives Rapporteur and Co-Rapporteur designation for BiovaxID personalized cancer vaccine

FDA grants Senesco's SNS01-T orphan-drug designation to treat lymphomas

Antioxidants and pancreatic cancer risk: an interview with Dr Andrew Hart

Promising implications for improving cellular immunotherapy for treatment of cancer

Positive results from Vermillion OVA500 multi-center study for ovarian cancer

Advaxis reports continued positive patient survival pattern in ADXS-HPV Phase 2 cervical cancer trial

FDA accepts Exelixis’ cabozantinib NDA for filing

MCW, Transgenomic partner to offer next-generation genetic testing services

PSA testing and early detection may prevent 17,000 men each year from prostate cancer

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in